Development of robust targeted proteomics assays for cerebrospinal fluid biomarkers in multiple sclerosis

BACKGROUND: Verification of cerebrospinal fluid (CSF) biomarkers for multiple sclerosis and other neurological diseases is a major challenge due to a large number of candidates, limited sample material availability, disease and biological heterogeneity, and the lack of standardized assays. Furthermo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Proteomics
Autors principals: Guldbrandsen, Astrid, Lereim, Ragnhild Reehorst, Jacobsen, Mari, Garberg, Hilde, Kroksveen, Ann Cathrine, Barsnes, Harald, Berven, Frode S.
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2020
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7499868/
https://ncbi.nlm.nih.gov/pubmed/32963504
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12014-020-09296-5
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars